Faculty

Bryan Kestenbaum

Adjunct Professor, Epidemiology
Professor, Medicine - Nephrology

206-685-7343
brk@uw.edu

Education

MD University of Massachusetts, 1995
MS Epidemiology, University of Washington, 2002
BS Microbiology, University of Massachusetts, 1991

Contact

206-685-7343
brk@uw.edu

University of Washington
Office BB1255
Box 359606
Kidney Research Institute (KRI)
325 9th Avenue
Seattle, WA 98104

Research Interests

Dr. Kestenbaum is a Nephrologist and Epidemiologist who studies the metabolic complications of kidney disease. His research group focuses on developing new methods for assessing kidney function, understanding the determinants and consequences of mineral metabolism disturbances, and investigating the impact of uremic toxins on skeletal muscle functioning. Their ongoing work spans large cohort studies to hands-on translational research within the Kidney Research Institute, a clinical and translational unit that houses a critical mass of investigators, study personnel, and staff.

Recent Publications (PubMed)

The plasma free fraction of 25-hydroxyvitamin D(3) is not strongly associated with 25-hydroxyvitamin D(3) clearance in kidney disease patients and controls.
(2022 Oct 28)
J Steroid Biochem Mol Biol 226(): 106206
Best CM, Thummel KE, Hsu S, Lin Y, Zelnick LR, Kestenbaum B, Kushnir MM, de Boer IH, Hoofnagle AN

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
(2022)
PLoS One 17(10): e0276649
Andrews M, Yoshida T, Henderson CM, Pflaum H, McGregor A, Lieberman JA, de Boer IH, Vaisar T, Himmelfarb J, Kestenbaum B, Chung JY, Hewitt SM, Santo BA, Ginley B, Sarder P, Rosenberg AZ, Murakami T, Kopp JB, Kuklenyik Z, Hoofnagle AN

Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General Population.
(2022 Oct 11)
Am J Kidney Dis
Kestenbaum B, Bick AG, Vlasschaert C, Rauh MJ, Lanktree MB, Franceschini N, Shoemaker MB, Harris RC Jr, Psaty BM, Köttgen A, Natarajan P, Robinson-Cohen C

Vitamin D, parathyroid hormone, glucose metabolism and incident diabetes in the multiethnic study of atherosclerosis.
(2022 Sep)
BMJ Open Diabetes Res Care 10(5):
Williams A, Zhao S, Brock G, Kline D, Echouffo-Tcheugui JB, Effoe VS, Bertoni AG, Michos ED, de Boer IH, Kestenbaum B, Golden SH, Joseph JJ

Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study.
(2022 Aug)
Clin J Am Soc Nephrol 17(8): 1183-1193
Akwo E, Pike MM, Ertuglu LA, Vartanian N, Farber-Eger E, Lipworth L, Perwad F, Siew E, Hung A, Bansal N, de Boer I, Kestenbaum B, Cox NJ, Ikizler TA, Wells Q, Robinson-Cohen C

Show complete publication list

In the News

Exercise May Slow Decline in Kidney Function
Journal of the American Society of Nephrology, 12/12/2013